UBS Global Wealth Management said it now has an attractive view on U.S. equities, supported in part by growing adoption of ...
The antibody drug conjugate didn’t help patients live longer in a confirmatory trial, prompting a review of its conditional approval.
However, though the target market is expected to undergo significant growth, factors like stringent cholesteryl isostearate ...